Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: September 2021

Workgroups: Maternal, Infant, and Child Health Workgroup

The U.S. Preventive Services Task Force recommends the use of low-dose aspirin to prevent preeclampsia in people who are more than 12 weeks pregnant and are at high risk for preeclampsia. Low-dose aspirin is 81 mg daily.

Read more about this resource

Objectives related to this resource (1)

Reduce maternal deaths — MICH‑04
LHI label
Little or no detectable change

Suggested Citation

1.

U.S. Preventive Services Task Force. (2021). Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication